Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Seasonal influenza virus vaccine quadrivalent - Sanofi Pasteur

Next Previous
Drug Profile

Seasonal influenza virus vaccine quadrivalent - Sanofi Pasteur

Alternative Names: Efluelda; FluQuadri; FluQuadri Junior; Fluzone High-Dose Quadrivalent; Fluzone QIV ID; Fluzone QIV IM; Fluzone Quadrivalent; Fluzone Quadrivalent vaccine; Fluzone-HD; High dose quadrivalent influenza vaccine; High-Dose Influenza Vaccine Quadrivalent; IIV4-HD; Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin; QIV; QIV - Sanofi pasteur; QIV-HD; Quadrivalent inactivated influenza virus vaccine; Quadrivalent influenza vaccine; Shenzhen quadrivalent influenza vaccine; Shz QIV; SP0178; Vaxigrip QIV IM; VaxigripTetra

Latest Information Update: 14 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur
  • Developer Sanofi K.K.; Sanofi Pasteur
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 12 Feb 2025 Sanofi plans regulatory application for Influenza virus infections (In adults, In the elderly) in 2026 (Sanofi pipeline, February 2025)
  • 04 Jan 2024 No development reported - Phase-III for Influenza virus infections (In adolescents, In children, In infants, Prevention, In adults) in Vietnam (IM)
  • 04 Jan 2024 No development reported - Phase-III for Influenza virus infections (In adolescents, In children, In the elderly, In infants, Prevention, In adults) in China (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top